Icatt

Ended Definitive Contract Awarded Last action

Contract number
75D30122C13957
Awardee
Awarding agency
Obligated
$4,197,407

Award facts

Opportunity
Contract value 100% obligated
$4,197,407.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 11 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Secaucus, NJ 07094, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00014 $0
Other Administrative Action P00013 -$232,383
Terminate for Convenience P00012 · EOI::implementing the president's doge cost efficiency initiative::EOI bilateral modification to descope -$49,977,100
Supplemental Agreement for work within scope P00011 $0
Supplemental Agreement for work within scope P00010 $0
Supplemental Agreement for work within scope P00009 $0
Other Administrative Action P00008 $0
Other Administrative Action P00007 $0
Supplemental Agreement for work within scope P00006 $0
Supplemental Agreement for work within scope P00005 $0
Other Administrative Action P00004 $0
Supplemental Agreement for work within scope P00003 $0
Supplemental Agreement for work within scope P00002 $0
Supplemental Agreement for work within scope P00001 $0
Original award $54,406,890
Show all 15

About this award

CDC Pittsburgh awarded a $4.197 million firm fixed-price definitive contract to Quest Diagnostics Incorporated for ICATT (pharmacy and community-based COVID-19 testing site operations) on June 29, 2022, with an ultimate completion date of May 31, 2025. The award carries no set-aside designation.

The originating solicitation, posted in January 2022, sought contractors to maintain approximately 20,000 pharmacy and community-based COVID-19 testing sites nationwide. The requirement called for demonstrated capability to operate over 500 testing sites, collect over 2 million samples, and perform over 100,000 tests, evaluated against the ICATT Mandatory Capabilities Checklist. Anticipated contract structure was firm fixed-price with a six-month base period and five six-month options through June 2028. Place of performance is Secaucus, NJ. The primary NAICS code is 621511 (medical laboratories).

Quick answers

Who was awarded contract 75D30122C13957?

75D30122C13957 was awarded to Quest Diagnostics Incorporated by CDC Pittsburgh (Centers for Disease Control and Prevention) on June 29, 2022.

How much is contract 75D30122C13957 worth?

The government has obligated $4,197,407 on 75D30122C13957.

Was contract 75D30122C13957 competed?

The extent of competition for 75D30122C13957 was full and open competition. The government received 11 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award